Sign up to save your podcasts
Or
Share A Pitch From Elucid
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
A Pitch From Elucid
In this week's episode, we hear a great pitch from Blake Richards CEO of Elucid. Followed by a Q&A and then a discussion between Martyn and Orrin
Global Health Impact Fund (GHIF) is a Strategic Venture Capital Investment Network. Our investor-focused model invests exclusively on behalf of our clinician and healthcare professional investor network. We provide an opportunity for these professionals to participate in a diversified portfolio of early-stage healthcare technology companies. These businesses are revolutionizing the healthcare industry, but the vast majority of clinical professionals are simply observers to changes that will upset their practices and worldview. GHIF offers a potent alternative to that scenario.
GHIF investors will directly help shape the technological cutting edge as executive advisors to the Fund. We care not just for your investment, but also for your opinions and participation. Our typical prospective investment will be seeking between $250K and $2M in capital. For businesses looking for more than $2M in the capital, we have the flexibility to co-invest alongside other strategic venture partners who meet our standards for commitment to healthcare improvement.
We would love to know what you took away from this conversation with Martyn and Orrin! Follow @martyneeles and give your insight and questions using the hashtag #GHIF. If you would like to be considered as a guest or have someone you would like to hear from (GP or LP), drop me a direct message on Twitter.
View all episodes
By Martyn Eeles
5
11 ratings
In this week's episode, we hear a great pitch from Blake Richards CEO of Elucid. Followed by a Q&A and then a discussion between Martyn and Orrin
Global Health Impact Fund (GHIF) is a Strategic Venture Capital Investment Network. Our investor-focused model invests exclusively on behalf of our clinician and healthcare professional investor network. We provide an opportunity for these professionals to participate in a diversified portfolio of early-stage healthcare technology companies. These businesses are revolutionizing the healthcare industry, but the vast majority of clinical professionals are simply observers to changes that will upset their practices and worldview. GHIF offers a potent alternative to that scenario.
GHIF investors will directly help shape the technological cutting edge as executive advisors to the Fund. We care not just for your investment, but also for your opinions and participation. Our typical prospective investment will be seeking between $250K and $2M in capital. For businesses looking for more than $2M in the capital, we have the flexibility to co-invest alongside other strategic venture partners who meet our standards for commitment to healthcare improvement.
We would love to know what you took away from this conversation with Martyn and Orrin! Follow @martyneeles and give your insight and questions using the hashtag #GHIF. If you would like to be considered as a guest or have someone you would like to hear from (GP or LP), drop me a direct message on Twitter.